Skip to content
Search

Latest Stories

PSNC urge pharmacy contractor to follow procedures for unplanned temporary closures

The Pharmaceutical Services Negotiating Committee (PSNC) has urged the pharmacy contractors to follow appropriate procedures for unplanned temporary closures due to current workforce pressure, to avoid a breach of terms of service.

“If the temporary closure is not for reasons beyond the contractor’s control, this may be a breach of the terms of service,” said PSNC.


The committee also informed that in some areas, NHS England regional teams may ask contractors to complete a new notification form for any temporary closures that request more information than the standard form, for example, on the mitigating actions taken by the contractor.

It added: “Completion of these forms is voluntary but may help to show NHS England that the closure was for reasons beyond the contractor’s control, or that the overall circumstances of the closure, including time closed and steps taken to ensure patient and public needs are met, indicate that there is no public interest in taking any regulatory/performance action (such as a breach notice) against the contractor.”

The procedures – as well as closing the premises and restricting entry/access – include the following:

  1. Notifying NHS England as soon as practical: There is an unplanned temporary suspension of services notification form which contractors should complete to notify NHS England of the temporary closure and the reasons for it.
  2. Updating the Directory of Services (DoS) and NHS website entries: Using NHS Profile Manager, contractors must update their DoS and the NHS website entries to ensure that they provide accurate information of the pharmacy’s opening hours to patients, the public, and other relevant NHS service providers.
  3. Trying to re-open the pharmacy: Contractors must use all reasonable endeavours to re-open and provide NHS pharmacy services as soon as practicable.
  4. Making alternative arrangements for the provision of NHS pharmacy services: Contractors must, where practicable, make alternative arrangements with one or more pharmacies in the area, for the ongoing provision of NHS pharmacy services.

Alternative arrangements for the ongoing provision of NHS pharmacy services are likely to include:

  1. Clinical: Identifying any urgent prescriptions which are awaiting dispensing, collection or delivery, such as those for antibiotics or analgesics, and making arrangements for the ongoing supply of medicines prescribed by installment prescriptions or supplied in monitored dosage systems. It is important that staff do as much as they can before they leave the premises to ensure patients are able to access their prescriptions.
  2. Information: Displaying clear notices advising patients and the public of the closure, including any arrangements for accessing their medicines and the estimated time when the pharmacy will re-open, and providing relevant information to those with, for example, urgent prescriptions.
  3. GPs: Informing local GP practices of the situation and any arrangements made with local pharmacies while the pharmacy is closed.

The committee is working with NHS England and the Department of Health and Social Care, as indicated in the CPCF Years 4 and 5 letter to contractors, to consider what can be done to relieve the current pressures contractors are facing.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less